Author

Adam C Resnick

Children's Hospital of Philadelphia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:scATAC-seq· 1

Frequent Co-Authors

Ana Guerreiro StückliniD· 1 shared Andrea Joseph De MicheliiD· 1 shared Andreas Postlmayr· 1 shared Carlos Alberto Oliveira de BiagiiD· 1 shared Charbel MachaalaniiD· 1 shared Chris JonesiD· 1 shared Costanza Lo CascioiD· 1 shared Cynthia E HawkinsiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ana Guerreiro StücklinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single-cell multi-omic analyses resolve the cellular diversity of ALK/ROS1/MET/NTRK-fused gliomas in infants and older children

Andrea Joseph De Micheli, Carlos Alberto Oliveira de Biagi, Costanza Lo Cascio, Charbel Machaalani, Andreas Postlmayr, Shashank Katiyar, Roeltje R. Maas, Venkatesh Kancherla, Regina Reimann, Michal Zápotocký, Liana Figueiredo Nobre, Sebastian K. Eder, Jacob S Rozowsky, Théo Ribierre, Fides Lea Zenk, , Ana Guerreiro Stücklin

The paper uses single-cell and spatial multi-omic analyses to characterize cellular diversity in RTK-fused gliomas across pediatric age groups, identifying distinct cancer cell states and myeloid subgroups.

bioRxiv · Jul 16, 2026 · PreprintCancer Biology

In vitro modeling of nutritional and mitochondria-targeted therapies for osteosarcoma

Min Peng, Kelsey Keith, Shrey Dalwadi, Vernon E. Anderson, Adam C Resnick, Marni J. Falk

This study evaluates metabolic and mitochondria-targeted therapies for osteosarcoma using in vitro models, finding that combined treatments like ONC201/ONC206/metformin show enhanced cytotoxicity with minimal toxicity to normal cells.

bioRxiv · Feb 20, 2026 · PreprintCancer Biology